🇺🇸 FDA
Pipeline program

Cyclophosphamide+Pemetrexed+5-Fluorouracil

HX20231471

Phase 2 small_molecule active

Quick answer

Cyclophosphamide+Pemetrexed+5-Fluorouracil for Locally Advanced Thyroid Gland Carcinoma is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Locally Advanced Thyroid Gland Carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials